
Continuous vs. batch production
While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…
The contract manufacturing space has gone from strength to strength in the last ten years and in an increasingly crowded marketplace, selecting the right contract partner is more important than ever before.
Growth in the emerging pharmaceutical sector, particularly in the US, is driving demand for contract services such as manufacturing capabilities. Added to this, pharmaceutical companies are divesting their internal capabilities to generate cost-savings and instead opting for outsourced services.
In this month’s Pharma Technology Focus our CEO, Kevin Cook discusses how CDMOs can take advantage of the market growth and differentiate their offering. Read the full roundtable here: http://bit.ly/2vLlCFj.
While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…
A conversation with Kevin Cook about CDMO-sponsor partnerships and outsourcing Kevin Cook, CEO at Sterling Pharma Solutions recently spoke with…
View our infographic to explore the growth of highly potent molecules and key considerations to unlock their full potential in…
There is a growing demand for hazardous chemistry techniques for synthetic manufacturing processes, propelled by the increasing complexity of new…